Prevalence of Brugada sign and syndrome in patients presenting with arrhythmic symptoms at a Heart Rhythm Clinic in Singapore.
OBJECTIVE
Southeast Asia is endemic for Brugada syndrome; however, its prevalence in Singapore is unknown. We aimed to determine the prevalence of Brugada sign [Types 1, 2, and 3 Brugada electrocardiogram (ECG)] and syndrome at an arrhythmia clinic in Singapore.


RESULTS
Patients who presented with pre-syncope, syncope, and/or palpitations without a known cause at an arrhythmia clinic between 2005 and 2007 were included in the study. The study criteria were met by 392 patients (age: 49.6 +/- 19.1 years, 55.9% male); 675 patients were excluded because they were referred for the management of known diagnoses. The 12-lead ECGs of these patients were analysed and clinical information was abstracted. Brugada sign was observed in 28 patients, and 12 patients were determined to have Brugada syndrome (age: 36.3 +/- 15.4 years, 100% male), yielding a prevalence of 7.1% [95% confidence interval (CI): 4.8-10.2] and 3.1% (95% CI: 1.6-5.3), respectively. The prevalence rates of patients with Type 1, Type 2, and Type 3 Brugada signs were 4.8% (95% CI: 2.9-7.5), 1.8% (95% CI: 0.7-3.6), and 0.5% (95% CI: 0.06-1.8), respectively. Over 30.4 person-years of follow-up, there was one inappropriate defibrillation shock but no appropriate shocks or sudden cardiac deaths among patients with Brugada sign or syndrome.


CONCLUSIONS
The prevalence of both Brugada sign and syndrome in a hospital-based population in Singapore was found to be high. Further population-based investigation is warranted to confirm these findings.
Sidik
Novalia P
NP
Cardiovascular Division, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 5 Lower Kent Ridge Road, Level 3, Singapore 119074, Republic of Singapore.
Quay
Chwee N
CN
Loh
Fong C
FC
Chen
Lin Y
LY
D000293:Adolescent; D000328:Adult; D001145:Arrhythmias, Cardiac / Q000453:epidemiology* / Q000209:etiology; D053840:Brugada Syndrome / Q000150:complications / Q000453:epidemiology* / Q000628:therapy; D017147:Defibrillators, Implantable; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012189:Retrospective Studies; D012846:Singapore / Q000453:epidemiology; D013575:Syncope / Q000453:epidemiology / Q000209:etiology; D016896:Treatment Outcome; D055815:Young Adult